泰恩康(301263.SZ)子公司盐酸伐地那非片药品注册申请获受理

智通财经02-21

智通财经APP讯，泰恩康(301263.SZ)公告，公司全资子公司山东华铂凯盛生物科技有限公司于近日收到国家药品监督管理局(简称“国家药监局”)签发的盐酸伐地那非片境内生产药品注册上市许可申请《受理通知书》。公告显示，盐酸伐地那非属于5型磷酸二酯酶(PDE-5)抑制剂，主要用于治疗男性勃起功能障碍(ED)，原研药Levitra由拜耳公司开发，2003年在欧盟首获批，后相继在美国、日本、加拿大、中国...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2413418257?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-02-21 15:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2413418257","market":"hk","top_or_hot":-1,"title":"泰恩康(301263.SZ)子公司盐酸伐地那非片药品注册申请获受理","media":"智通财经","content":"<div>\n<p>智通财经APP讯，泰恩康(301263.SZ)公告，公司全资子公司山东华铂凯盛生物科技有限公司于近日收到国家药品监督管理局(简称“国家药监局”)签发的盐酸伐地那非片境内生产药品注册上市许可申请《受理通知书》。公告显示，盐酸伐地那非属于5型磷酸二酯酶(PDE-5)抑制剂，主要用于治疗男性勃起功能障碍(ED)，原研药Levitra由拜耳公司开发，2003年在欧盟首获批，后相继在美国、日本、加拿大、中国...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1074361.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>泰恩康(301263.SZ)子公司盐酸伐地那非片药品注册申请获受理</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n泰恩康(301263.SZ)子公司盐酸伐地那非片药品注册申请获受理\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-21 15:53 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1074361.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，泰恩康(301263.SZ)公告，公司全资子公司山东华铂凯盛生物科技有限公司于近日收到国家药品监督管理局(简称“国家药监局”)签发的盐酸伐地那非片境内生产药品注册上市许可申请《受理通知书》。公告显示，盐酸伐地那非属于5型磷酸二酯酶(PDE-5)抑制剂，主要用于治疗男性勃起功能障碍(ED)，原研药Levitra由拜耳公司开发，2003年在欧盟首获批，后相继在美国、日本、加拿大、中国...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1074361.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1074361.html","article_id":"2413418257","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2413418257","pubTimestamp":1708502030,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，泰恩康(301263.SZ)公告，公司全资子公司山东华铂凯盛生物科技有限公司于近日收到国家药品监督管理局(简称“国家药监局”)签发的盐酸伐地那非片境内生产药品注册上市许可申请《受理通知书》。公告显示，盐酸伐地那非属于5型磷酸二酯酶(PDE-5)抑制剂，主要用于治疗男性勃起功能障碍(ED)，原研药Levitra由拜耳公司开发，2003年在欧盟首获批，后相继在美国、日本、加拿大、中国等多国上市。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4585":"ETF&股票定投概念","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK4588":"碎股","BK4208":"复合型公用事业","ED":"爱迪生联合电气"},"translate_title":"The application for drug registration of vardenafil hydrochloride tablets of Taienkang (301263. SZ) subsidiary was accepted","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ED":1},"content_text":"智通财经APP讯，泰恩康(301263.SZ)公告，公司全资子公司山东华铂凯盛生物科技有限公司于近日收到国家药品监督管理局(简称“国家药监局”)签发的盐酸伐地那非片境内生产药品注册上市许可申请《受理通知书》。公告显示，盐酸伐地那非属于5型磷酸二酯酶(PDE-5)抑制剂，主要用于治疗男性勃起功能障碍(ED)，原研药Levitra由拜耳公司开发，2003年在欧盟首获批，后相继在美国、日本、加拿大、中国等多国上市。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2413418257"}